These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1673786)

  • 41. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relapse of duodenal ulcers after successful eradication of Helicobacter pylori in gastric ulcer patients.
    Sou Y; Saita H; Takahashi Y; Yoshinaga T; Matsukawa Y; Sekikawa A; Nakazawa T; Shio S; Kohigashi K
    J Gastroenterol; 1999; 34 Suppl 11():84-90. PubMed ID: 10616773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine.
    Pan SA; Liao CH; Lien GS; Chen SH
    Gastroenterology; 1991 Nov; 101(5):1187-91. PubMed ID: 1936788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of sucralfate on Helicobacter pylori and severity of gastritis in patients with duodenal ulcer.
    Winter TA; Louw JA; Marks IN; Jaskiewicz K; Lucke W; Callanan M
    Scand J Gastroenterol Suppl; 1995; 210():85-8. PubMed ID: 8578216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Short-term eradication therapy for Helicobacter pylori does not reduce the incidence of gastric metaplasia in duodenal ulcer patients.
    Rudnicka L; Bobrzyński A; Stachura J
    Pol J Pathol; 1997; 48(2):103-6. PubMed ID: 9278106
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of colloidal bismuth subcitrate and metronidazole, both in combination with an H2-antagonist as therapy for Helicobacter pylori.
    Baffone W; Belbusti F; Barbieri E; Pianetti A; Bruscolini F; Fabi MT; Salvaggio L; Albano A
    J Chemother; 1997 Jun; 9(3):208-12. PubMed ID: 9210004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapy of resistant duodenal ulcer].
    Vigneri S; Scialabba A; Pisciotta G; Termini R; Muratore F; Vinti M
    Minerva Med; 1989 Nov; 80(11):1205-10. PubMed ID: 2574838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of duodenal ulcer concomitant with successful Helicobacter pylori eradication.
    Pohle T; Hilker E; Domschke W
    Z Gastroenterol; 1997 Jul; 35(7):563-5. PubMed ID: 9273989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptic disease: can we afford current management?
    Fletcher DR
    Aust N Z J Surg; 1997; 67(2-3):75-80. PubMed ID: 9068546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
    Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
    Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
    Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bismuth: effects on gastritis and peptic ulcer.
    Rokkas T; Sladen GE
    Scand J Gastroenterol Suppl; 1988; 142():82-6. PubMed ID: 3047853
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colloid bismuth versus famotidine in the treatment and prevention of duodenal ulcer relapse: results of a double-blind, double dummy randomized study.
    Masci E; Colombo E; Testoni PA; Fanti L; Guslandi M; Tittobello A
    Fundam Clin Pharmacol; 1995; 9(3):280-3. PubMed ID: 7557824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medical treatment of peptic ulcer disease.
    Rubin W
    Med Clin North Am; 1991 Jul; 75(4):981-98. PubMed ID: 1677060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Management of duodenal ulcer except in emergency: surgical treatment].
    Michot F; Fraleu-Louer B
    Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S64-S72. PubMed ID: 8734373
    [No Abstract]   [Full Text] [Related]  

  • 57. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
    Xia HX; Gilvarry J; Beattie S; Hamilton H; Keane CT; Sweeney EC; O'Morain CA
    Am J Gastroenterol; 1995 Aug; 90(8):1221-5. PubMed ID: 7639218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of colloidal bismuth subcitrate on duodenal ulcer relapse.
    Bianchi Porro B; Lazzaroni M; Parente F; Petrillo M
    Scand J Gastroenterol Suppl; 1986; 122():35-8. PubMed ID: 3535020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of different strategies for treatment of duodenal ulcer.
    Sonnenberg A
    Br Med J (Clin Res Ed); 1985 Apr; 290(6476):1185-7. PubMed ID: 2859078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relative effectiveness and costs of antiulcer medications as a basis for rational prescribing.
    McLean AJ; Harcourt DM; McCarthy PG; Dudley FJ; McNeil JJ
    Med J Aust; 1987 Apr; 146(8):431-3, 436-8, 442. PubMed ID: 2886896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.